R Venkat Subramanian of Kotak Securities is of the view that one can ignore FMCG, pharma space.
Subramanian told CNBC-TV18, "At this stage the market and when the broader market is completely bombed out and as an investor if you have any amount of risk appetite you should be buying things, which can do well as the market improves. This is not the time to hide behind the stocks, which will not fall. I think that is good and if you had done that in the market 15,000 or 20,000 that is good. But at this stage I would be little more aggressive in looking for stocks, which can go up than to look at stocks which will not go down. So I would ignore FMCG and even pharma for that matter."
Disclosure: It is safe to assume that analyst and his clients may have an investment interest in the above stock/sector.
